skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

Neuropsychiatric Disease and Treatment

(2,361,228) Views

Editor in Chief Dr Roger M Pinder

1176-6328

Other
Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976
Colombo GL, Caruggi M, Di Matteo, et al
Neuropsychiatric Disease and Treatment 2008, 4:1283-1283
03 February 2009

Case report
Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes
Atsuko Ikenouchi-Sugita, Reiji Yoshimura, Nobuhisa Ueda, Yuki Kodama, Wakako Umene-Nakano, Jun Nakamura
Neuropsychiatric Disease and Treatment 2008, 4:1277-1281
13 October 2008

Case report
Mirror movement associated with neural tube defects
Yasir Andrabi, Farideh Nejat, Mostafa El Khashab, Mohammad Reza Ashrafi
Neuropsychiatric Disease and Treatment 2008, 4:1273-1276
14 September 2008

Original Research
Progression to vascular dementia of patients with mild cognitive impairment: relevance of mild parkinsonian signs
Marco Mauri, Simona Corbetta, Cristina Pianezzola, Elena Ambrosoni, Giulio Riboldazzi, Giorgio Bono
Neuropsychiatric Disease and Treatment 2008, 4:1267-1271
30 October 2008

Original Research
Methylphenidate modulates activity within cognitive neural networks of patients with post-stroke major depression: A placebo-controlled fMRI study
Rajamannar Ramasubbu, Bradley G Goodyear
Neuropsychiatric Disease and Treatment 2008, 4:1251-1266
15 October 2008

Original Research
Post-traumatic stress, depression, and anxiety in patients with injury-related chronic pain: A pilot study
Sofia Åhman, Britt-Marie Stålnacke
Neuropsychiatric Disease and Treatment 2008, 4:1245-1249
30 October 2008

Original Research
Premorbid intelligence of inpatients with different psychiatric diagnoses does not differ
Paolo Stratta, Ilaria Riccardi, Annarita Tomassini, Maria Marronaro, Roberta Pacifico, Alessandro Rossi
Neuropsychiatric Disease and Treatment 2008, 4:1241-1244
07 October 2008

Original Research
Clinical presentation of anxiety among patients with epilepsy
M López-Gómez, M Espinola, J Ramirez-Bermudez, I E Martinez-Juarez, A L Sosa
Neuropsychiatric Disease and Treatment 2008, 4:1235-1239
14 September 2008

Original Research
SPEEDY babies: A putative new behavioral syndrome of unbalanced motor-speech development
Marja-Leena Haapanen, Tuomo Aro, Elina Isotalo
Neuropsychiatric Disease and Treatment 2008, 4:1225-1233
23 September 2008

Expert Opinion
Pregabalin for the management of partial epilepsy
Philippe Ryvlin, Emilio Perucca, Sylvain Rheims
Neuropsychiatric Disease and Treatment 2008, 4:1211-1224
27 November 2008

Review
Mycophenolate mofetil for myasthenia gravis: a clear and present controversy
Chad Heatwole, Emma Ciafaloni
Neuropsychiatric Disease and Treatment 2008, 4:1203-1209
06 November 2008

Review
New treatment options in the management of fibromyalgia: role of pregabalin
Grazyna Zareba
Neuropsychiatric Disease and Treatment 2008, 4:1193-1201
26 September 2008

Review
New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
Bernhard T Baune
Neuropsychiatric Disease and Treatment 2008, 4:1181-1192
02 October 2008

Review
Duloxetine in the treatment of generalized anxiety disorder
Trevor R Norman, James S Olver
Neuropsychiatric Disease and Treatment 2008, 4:1169-1180
12 January 2009

Review
Prophylaxis of migraine: general principles and patient acceptance
Domenico D’Amico, Stewart J Tepper
Neuropsychiatric Disease and Treatment 2008, 4:1155-1167
23 December 2008

Review
Bipolar disorder and neurophysiologic mechanisms
Simon M McCrea
Neuropsychiatric Disease and Treatment 2008, 4:1129-1153
20 November 2008

Review
Neurosurgical strategies for Gilles de la Tourette’s syndrome
Karim Mukhida, Matthew Bishop, Murray Hong, Ivar Mendez
Neuropsychiatric Disease and Treatment 2008, 4:1111-1128
30 September 2008

Review
Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature
Daniel J Abrams, Donald C Rojas, David B Arciniegas
Neuropsychiatric Disease and Treatment 2008, 4:1089-1109
27 November 2008

Review
An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS)
Salvador Harguindey, Gorka Orive, Ramón Cacabelos, Enrique Meléndez Hevia, Ramón Díaz de Otazu, et al
Neuropsychiatric Disease and Treatment 2008, 4:1073-1087
30 October 2008

Review
Treatment options and patient perspectives in the management of fibromyalgia: future trends
Kim Lawson
Neuropsychiatric Disease and Treatment 2008, 4:1059-1071
16 November 2008

Review
Current migraine management – patient acceptability and future approaches
Arnaud Fumal, Jean Schoenen
Neuropsychiatric Disease and Treatment 2008, 4:1043-1057
17 October 2008

Review
An update on the toxicity of Aβ in Alzheimer’s disease
Jürgen Götz, Lars M Ittner, Nicole Schonrock, Roberto Cappai
Neuropsychiatric Disease and Treatment 2008, 4:1033-1042
11 December 2008

Review
Gelastic seizures associated with hypothalamic hamartomas. An update in the clinical presentation, diagnosis and treatment
José F. Tellez-Zenteno, Cesar Serrano-Almeida, Farzad Moien-Afshari
Neuropsychiatric Disease and Treatment 2008, 4:1021-1031
15 October 2008

Review
Treatment of Lennox-Gastaut syndrome: overview and recent findings
Kenou van Rijckevorsel
Neuropsychiatric Disease and Treatment 2008, 4:1001-1019
11 November 2008